Skip to content

Clinical trials

Heartburn trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heartburn Country / region: United States Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20054
20067
20072
20086
20099
20104
20113
20122
20133
20144
20152
20163
20181
20193
20201
20212
20223
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Unknown status6
Terminated4
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
AstraZeneca6
Novartis6
Mayo Clinic4
Phathom Pharmaceuticals, Inc.4
Southern Arizona VA Health Care System3
University of North Carolina, Chapel Hill3
Eisai Inc.2
EndoGastric Solutions2
Microbiome Health Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heartburn72
Gastroesophageal Reflux47
Dyspepsia8
Esophagitis6
Barrett Esophagus4
Abdominal Pain3
Laryngopharyngeal Reflux3
Sleep Initiation and Maintenance Disorders3
Anxiety Disorders2
Diarrhea2

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.